Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235239641830207X |
id |
doaj-483f9c49b79b441694f3786eaf80902b |
---|---|
record_format |
Article |
spelling |
doaj-483f9c49b79b441694f3786eaf80902b2020-11-25T00:06:58ZengElsevierEBioMedicine2352-39642018-07-0133253268Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug DiscoveryValentina Benedetti0Valerio Brizi1Patrizia Guida2Susanna Tomasoni3Osele Ciampi4Elena Angeli5Ugo Valbusa6Ariela Benigni7Giuseppe Remuzzi8Christodoulos Xinaris9IRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyNanomed Laboratories, Dipartimento di Fisica, Università di Genova, 16146 Genova, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy; ‘L. Sacco’ Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, 24127 Bergamo, ItalyIRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, 24126 Bergamo, Italy; Corresponding author at: IRCCS – Istituto di Ricerche Farmacologiche ‘Mario Negri’ - Centro Anna Maria Astori, Department of Molecular Medicine, Laboratory of Organ Regeneration, Science and Technology Park Kilometro Rosso, Via Stezzano, 87, 24126 Bergamo, Italy.The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made 3D tubules with typical renal epithelial properties. This system was successfully employed to engineer patient-specific tubules, to model polycystic kidney disease (PKD) and test drug efficacy, and to identify a potential new pharmacological treatment. By optimizing our system we constructed functional ureteric bud (UB)-like tubules from human induced pluripotent stem cells (iPSCs), and identified a combination of growth factors that induces budding morphogenesis like embryonic kidneys do. Finally, we applied this assay to investigate budding defects in UB-like tubules derived from a patient with a PAX2 mutation.Our system enables the modeling of human kidney disease and development, drug testing and discovery, and lays the groundwork for engineering anatomically correct kidney tissues in vitro and developing personalized medicine applications. Keywords: Tubule engineering, Human pluripotent stem cells, Polycystic kidney disease, Ureteric bud, Drug discovery, PAX2http://www.sciencedirect.com/science/article/pii/S235239641830207X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Valentina Benedetti Valerio Brizi Patrizia Guida Susanna Tomasoni Osele Ciampi Elena Angeli Ugo Valbusa Ariela Benigni Giuseppe Remuzzi Christodoulos Xinaris |
spellingShingle |
Valentina Benedetti Valerio Brizi Patrizia Guida Susanna Tomasoni Osele Ciampi Elena Angeli Ugo Valbusa Ariela Benigni Giuseppe Remuzzi Christodoulos Xinaris Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery EBioMedicine |
author_facet |
Valentina Benedetti Valerio Brizi Patrizia Guida Susanna Tomasoni Osele Ciampi Elena Angeli Ugo Valbusa Ariela Benigni Giuseppe Remuzzi Christodoulos Xinaris |
author_sort |
Valentina Benedetti |
title |
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery |
title_short |
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery |
title_full |
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery |
title_fullStr |
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery |
title_full_unstemmed |
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery |
title_sort |
engineered kidney tubules for modeling patient-specific diseases and drug discovery |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2018-07-01 |
description |
The lack of engineering systems able to faithfully reproduce complex kidney structures in vitro has made it difficult to efficiently model kidney diseases and development. Using polydimethylsiloxane (PDMS) scaffolds and a kidney-derived cell line we developed a system to rapidly engineer custom-made 3D tubules with typical renal epithelial properties. This system was successfully employed to engineer patient-specific tubules, to model polycystic kidney disease (PKD) and test drug efficacy, and to identify a potential new pharmacological treatment. By optimizing our system we constructed functional ureteric bud (UB)-like tubules from human induced pluripotent stem cells (iPSCs), and identified a combination of growth factors that induces budding morphogenesis like embryonic kidneys do. Finally, we applied this assay to investigate budding defects in UB-like tubules derived from a patient with a PAX2 mutation.Our system enables the modeling of human kidney disease and development, drug testing and discovery, and lays the groundwork for engineering anatomically correct kidney tissues in vitro and developing personalized medicine applications. Keywords: Tubule engineering, Human pluripotent stem cells, Polycystic kidney disease, Ureteric bud, Drug discovery, PAX2 |
url |
http://www.sciencedirect.com/science/article/pii/S235239641830207X |
work_keys_str_mv |
AT valentinabenedetti engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT valeriobrizi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT patriziaguida engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT susannatomasoni engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT oseleciampi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT elenaangeli engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT ugovalbusa engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT arielabenigni engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT giusepperemuzzi engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery AT christodoulosxinaris engineeredkidneytubulesformodelingpatientspecificdiseasesanddrugdiscovery |
_version_ |
1725420695249223680 |